Gene · 2012
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Iron, Ferroptosis, and Head and Neck Cancer. | Int J Mol Sci | 2023 | 37894808 | PubTator, text mining | PubMed |
| Monophasic Variant of Salmonella Typhimurium 4,[5],12:i:- (ACSSuGmTmpSxt Type) Outbreak in Central Italy Linked to the Consumption of a Roasted Pork Product (Porchetta). | Microorganisms | 2023 | 37894225 | PubTator, text mining | PubMed |
| Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases. | Hepatobiliary Surg Nutr | 2023 | 37886182 | PubTator, text mining | PubMed |
| Protrieve sheath utilization for capturing supra-filter thrombus during a retrieval of thrombosed and embedded IVC filter. | CVIR Endovasc | 2023 | 37882904 | PubTator, text mining | PubMed |
| Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. | Front Immunol | 2023 | 37881427 | PubTator, text mining | PubMed |
| TEAD4 antagonizes cellular senescence by remodeling chromatin accessibility at enhancer regions. | Cell Mol Life Sci | 2023 | 37856006 | PubTator, text mining | PubMed |
| A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling. | Int Med Case Rep J | 2023 | 37840970 | PubTator, text mining | PubMed |
| The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies. | Cell Biosci | 2023 | 37828613 | PubTator, text mining | PubMed |
| Integrome signatures of lentiviral gene therapy for SCID-X1 patients. | Sci Adv | 2023 | 37801507 | PubTator, text mining | PubMed |
| Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. | MedComm (2020) | 2023 | 37799806 | PubTator, text mining | PubMed |
Specific Oral Microbial Differences in Proteobacteria and Bacteroidetes Are Associated with Distinct Sites When Moving from Healthy Mucosa to Oral Dysplasia-A Microbiome and Gene Profiling Study and Focused Review. | Microorganisms | 2023 | 37764094 | PubTator, text mining | PubMed |
| Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases. | Cell Death Dis | 2023 | 37739961 | PubTator, text mining | PubMed |
| Novel potential urinary biomarkers for effective diagnosis and prognostic evaluation of high-grade bladder cancer. | Transl Cancer Res | 2023 | 37701108 | PubTator, text mining | PubMed |
| The gut microbiome of the healthy population in Kolkata, India, is a reservoir of antimicrobial resistance genes emphasizing the need of enforcing antimicrobial stewardship. | FEMS Microbiol Lett | 2023 | 37697657 | PubTator, text mining | PubMed |
| A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer. | iScience | 2023 | 37694141 | PubTator, text mining | PubMed |
| Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. | Cancers (Basel) | 2023 | 37686696 | PubTator, text mining | PubMed |
| Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson's Disease. | Int J Mol Sci | 2023 | 37686360 | PubTator, text mining | PubMed |
| CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. | Exp Hematol Oncol | 2023 | 37679762 | PubTator, text mining | PubMed |
| The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. | JCI Insight | 2023 | 37669110 | PubTator, text mining | PubMed |
| Identification of potential key genes of TGF-beta signaling associated with the immune response and prognosis of ovarian cancer based on bioinformatics analysis. | Heliyon | 2023 | 37664697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2012/papers?page=9